Gland Pharma Limited IPO Message Board (Page 13)

I already told you, too high price, you will get in open market below 1000 in coming days. Good response from retail investors as they didn't apply in this IPO. Those who applied they will get 100% allotment. Exit early.

Give some good reason for price to go down. More stronger hands are currently holding equity and enough headroom for FII to participate

Divis Lab > Sept Qtr EPS is Rs 19, tad bit lower than Gland

Trades at 3400+

isnt face value of share matters when arriving stock price?

@Ram
No face value does not matter. What matters is the book value or NAV when you compare it with EPS
As we all know Britannia is a good stock but it's face value is 1.

Annualized EPS based on Q1 is Rs 80.

PE of even 20 = 1600 Rs per share

PE of 30 (Normal valuation) = 2400 Rs per share

PE of 40 (Valuation for high growth, moated companies) = INR 3200 Rs per share.

Do you still want to sell on listing day?

PREMIUM 45-49

If it goes below 1500, I will buy and if goes below 1000 I will buy more. I don't see anything wrong in the business. Well performing company and consistently making profit.

China’s regulatory authority accepts Fosun Pharma clinical trial application of mRNA vaccine BNT162b2 for COVID-19

Please visit the bwlow link for detailed information
https://www.globaltimes.cn/content/1206562.shtml

Some of boarder are giving wild figures for Gland without giving any reason. I respect all of them. However, would request to state the reason why?
It may turn out right or wrong but it is better than i feel so
I see mutual fund further demand emerging post January 31, 2021 when it officially becomes part of large cap club. Don't worry even at 1400 it would be part of that club as top 100 club last script is around Rs 20000 crore market cap

Yesterday just looking at QIB subscriber on NSE and BSE, FII, Domestic mutual fund, Insurance companies and surprising the fourth (as I understand) was Pvt Companies.
Promoter Fosun pharma was holding 74% pre IPO and after IPO 58%.
So Foreign investment allowed in this company upto 74%. And the anchor placement and QIB subscription shows that Foreign investment will not cross 65.

Listing in my opinion will be in 1400-1580 range. 2nd Quarter result is due also.

Company fundamentls are good except the chinese promotors.
Apply with full force for short / mid and longterm investment.

No need to apply now for medium to long term .
We can buy after listing , here problem and question is listing gains that's it
Any one can say blindly medium to long term

Hi
The chances of listing discount is very low..
The retails n HNI's who applied for this IPO are aware of GMP n applied based on longterm view..
I dont think QIB's sell the shares due to chinese promotors.
QIB's motivated to apply b'coz so far Gland pharma did not received any warning letter from USFDA. I am so confident that QIB dose not apply to make listing gains n shortterm profits..
If there are no sellers for the shares, then the chances of listing shares in discount is very low..

This remembers me the issue happened with sheela foam ipo, A good company marketed bad in social media n people realised the value of company on listing day n bought shares at 30% premium.

Market has rallied to all time highs and quite unexpectedly so but do we all feel our portfolio did not do as well? This is true for all retail investors like us. Small and Mid caps have grossly underperformed and a mega mega rally is due big! World has so much liquidity that money is bound to come in equity and beyond a point Large caps will become very expensive. After lot of research, I have come up with a list of small and mid caps which look very promising for excellent returns with very limited downside. So here are my Diwali 2020 picks. Do your own research and take decisions based on your risk appetite:

1) Welspun India. CMP 64. Target 120. 1 year.
2) Route Mobile. CMP 900. Target 1800-1900. 1 year.
3) GIC Re. CMP 124. Target 275. 1-2 Years.
4) AB capital. CMP 72. Target 150. 6 months.
5) Ujjivan Small Finance Bank. CMP 33. Target 75. 1 year.
6) RBL Bank. CMP 205. Target 400. 1 year.
7) Yes Bank. CMP 14. Target 25. 1 year.
8) IDFC First Bank. CMP 33. Target 115. 2 years.
9) Vodafone Idea. CMP 8.50. Target 18-20. 6 months. High risk. Maintain stop loss @ 4.90.
10) JM Financials. CMP 76. Target 125. 6 months.
11) BEL. CMP 95. Target 145. 6 months.
12) Chemcon. CMP 415. Target 650. 6 months.High risk. keep close watch on results and management commentary.
13) Happiest Minds. CMP 315. Target 450. 9 months.
14) SAIL. CMP 39.50. Target 75. 6 months.
15) SBI Cards. CMP 805. Target 1200. 1 year.

good luck. all these companies have healthy business, shown great resillience in results in pandemic, attractive valuations, very little downside, huge potential, good management!

this helped a lot to me... thanks @sauravk

please suggest stocks to buy as on current date.

The listing prediction is all over the place.

1450 1400 1300 1250 1175 ....

if the price goes below 1250, then I think I will buy and hold for the long term.

Fair value 1175 ....also china connection..so strict no-no

Chinese connection ? So what ? Are Chinese mobiles banned ? Please do not be symbolic.

1175 come after split ye bhag gya 1800 ke pas bhul jao 1175 me buy krne ka

HOS:

Lisitng be Good Expt 1700
Current Bhav 34

Hold for 1 Year target is 2500

Gland Pharma IPO
GMP 31 +/- 1

Eagleye ur expected listing price... Will it surprise positively...

Anti national qib subscribe 2.3 times already......

Also if the govt GOI has allowed the company to own legally, are you saying the GOI is also Anti National????

If something is wrong the GOI and Modiji will never allow it to operate in India... Until Modiji says otherwise, we cant oppose Modijis Decision.....

Logic is important when we say some things.....

Govt changed policy immediately when a Chinese investor bought hdfc during lockdown......so govt can barred anything chinese beneficial.in future...

It looks like post listing of the stock we may get the shares at a good value around 1200.
Not sure in just 2 years what has changed in structure of company. Chinese promotors paid around 600+ per share and in 2 years they are offering share for more than the double the cost price.
Looks like if the same trend continues by afternoon retail investors may withdraw their tendered applications.
Should be a good lesson for greedy promotors.
Big investors and fund houses invest public money and they are not going to loose anything. Retail investors are the group which will be mainly impacted by investing in such overvalued stocks.

If you are not sure in last two years price from 600 to asking price 1500...then on what basis your are saying post listing it will be available at 1200???

If you don't have data behind what you are saying better keep your view with yourself...

I think this IPO will break the GMP monopoly. I strongly believe this will be a bull in next few months.

Those who have applied.. ignore all talk of GMP and everything else. This is a gem to be treated as gold. Just dont sell on listing day for few gains or to book paper losses.

Listing around 1250 to 1300

Basis of statement. ?
All HNI and retail investor have put in money knowing that they will get full allotment.
I dont know any one who will knowingly take risk (there is no lottery) and everyone who applied knew about poor GMP
So why should it open low? There should be some logic? All existing investors shares will be locked in barring ED's share
And amount of time they took to dispose HM's share is well known

Gland Pharma IPO
GMP 28 +/- 1

GMP improving

Investors caught napping